CORPORATE STRATEGY

Corporate Strategies enable effective growth through understanding the critical value drivers for franchise and therapeutic area expansion.

  • Growth Strategy Development
  • Franchise Expansion
  • Emerging-Company Partnering Strategy

Franchise Expansion

Read More▼

Determine technology white spaces that could synergistically improve top line growth.

Read about how we helped a large Medtech/Diagnostic client:

SITUATION

  • Global medical technology company with a $1B+ cardiac surgical presence required additional high margin revenue generators as its business changed from surgery to catheter based interventions

OUR APPROACH

  • Via the lens of the cardiac surgical patient journey, analyzed the constellation of peri-operative unmet needs that could improve patient outcomes and physician performance
  • Considered devices and services across the spectrum of patient needs in order to reflect holistic changes in cardiac care and ability to achieve market dominance
  • Identified a range of white spaces and evaluated the rationale behind the technology and its proposed role in patient care

RESULT

  • Enabled client to look beyond cardiac surgical devices into opportunities such as diagnostic testing/monitoring, IT-based decision and patient support, and convergent drug delivery technologies

Emerging Company Partnering Strategy

Read More▼

Evaluate and prioritize programs to determine their growth potential and strategic relevance.

Read about how we helped a small Pharma/Biotech client:

SITUATION

  • Emerging biotech focused on small molecule therapies in Oncology/Autoimmune needed to assess the strategic options for four key assets and determine the optimal path for their development and commercialization

OUR APPROACH

  • Analyze each program's potential role in the treatment paradigm and understand the product's positioning and commercial potential
  • Understand the deal landscape and determine the optimal timing for a partnering/exit to maximize return and provide the greatest likelihood of finding an appropriate partner
  • Prioritize programs based on expected return on investment

RESULT

  • Defined expectations for deal metrics by stage of development, partner characteristics, and deal structure
  • Provided clear understanding of the relative strategic value of each program, resulting in reprioritization of client's pipeline

Emerging Company Partnering Strategy

Read More▼

Integrate drivers of clinical adoption with the needs of potential partners to develop achievable partnering strategies for emerging growth clients.

Read about how we helped a small Pharma/Biotech client:

SITUATION

  • Emerging biotech sought to understand strategic options and optimal positioning for lead asset in T2D

OUR APPROACH

  • Explore potential role of the product in T2D treatment paradigm and optimal early-stage development plan
  • Understand expected data that would provide interval proof of attractiveness for partnering at immediate preclinical and early clinical stage time points
  • Prioritize potential partners and gauge initial receptivity to product mechanism through focused discussions with R&D/Business Development leadership
  • Define likely deal structures and terms with relevant value inflection points at various development stages

RESULT

  • Optimal preclinical and early-clinical data package identified to attract potential partners
  • Defined expectations for deal metrics by stage of development, partner characteristics, and deal structure

Proven

Results complete
the circle.

Here are some of the challenges Back Bay has helped our clients meet:

Global medical technology company with a $1B+ cardiac surgical presence required...
read more

Global biopharmaceutical company needed to prioritize and determine the commercial...
read more

See all impact studies.

Background Image